Oncology Program
For decades, the Pediatric Oncology Program has been at the forefront of researching and treating childhood cancers. We're committed to helping our patients access the latest innovations in cancer care, and we're often among the first centers to offer new techniques as they become available. All of our programs are designed specifically for diagnosing and treating children with cancer.
Compassionate medical care is complemented by a wide range of services designed to support the well-being of patients and their families throughout this challenging time. Knowing that undergoing cancer treatment is emotionally difficult, we offer not just a helping hand but a hand to hold.
In addition to treating patients, our specialists lead world-class research aimed at advancing the understanding and treatment of cancer in children. Thanks to that work, our patients often have opportunities to participate in large-scale clinical trials of experimental drugs or other promising therapies.
Our overarching goal is to help kids get better as quickly as possible so they can put cancer behind them and get on with their lives. Thanks to the skill and dedication of our team, we're able to make the future brighter for so many of the patients who come to us.
Our locations (3)
Highlights of our cancer care

Leading-edge treatments
We're among the first to offer new treatment options, as soon as they're proven safe and effective. In addition, patients can access promising experimental therapies by participating in one of our many clinical trials.
Precision medicine
High-risk tumors are analyzed with the UCSF500 Cancer Gene Panel, a state-of-the-art test that identifies mutations in the tumor's DNA. The results can indicate the best treatment course and, in some cases, clarify the exact type of cancer.
Seamless care, near and far
Dedicated patient navigators help families with managing referrals, insurance concerns and appointment planning. We work with patients and referring doctors well beyond the San Francisco Bay Area, thanks to our comprehensive telehealth system.
Thorough follow-up
Our Pediatric Survivorship Program provides expert care to address any medical, psychological or social issues that arise after treatment is complete. The team also ensures smooth transitions to adult care providers as our patients leave childhood behind.
Our team
-
Anuradha Banerjee
MD
Pediatric Hematology-Oncology -
Benjamin S. Braun
MD, PhD
Hematology and Medical Oncology, Medical Oncology -
Maria I. Castellanos
MD
Pediatric Hematology-Oncology -
Robert E. Goldsby
MD
Hematology and Medical Oncology, Medical Oncology -
Caroline Hastings
MD
Pediatric Hematology-Oncology (Neuro-Oncology), Pediatric Hematology-Oncology -
Benjamin J. Huang
MD
Hematology and Medical Oncology, Medical Oncology -
Marie Jaeger-Krause
MD
Pediatric Hematology-Oncology (Neuro-Oncology), Pediatric Hematology-Oncology -
Rohini Jain
MD
Pediatric Hematology-Oncology -
Benjamin Lerman
MD
Pediatric Hematology-Oncology -
Anya Levinson
MD
Pediatric Hematology-Oncology -
Amanda Marinoff
MD
Pediatric Hematology-Oncology -
Jennifer Michlitsch
MD
Pediatric Hematology-Oncology -
Sabine Mueller
MD, PhD
Pediatric Hematology-Oncology (Neuro-Oncology), Pediatric Neurology -
Brian S. Na
MD, PhD
Neuro-Oncology -
Philip Pauerstein
MD, PhD
Pediatrics, Pediatric Hospital Medicine -
Cheryl Peretz
MD
Pediatric Hematology-Oncology -
Bo Qiu
MD, PhD
Pediatrics -
Karen Rabin
MD, PhD
Pediatric Hematology-Oncology -
Ruyan Rahnama
MD, PhD
Pediatric Hematology-Oncology -
Alyssa Reddy
MD
Pediatric Neurology -
Elizabeth Robbins
MD
Hematology and Medical Oncology, Medical Oncology -
Amit J. Sabnis
MD, MS
Hematology and Medical Oncology, Medical Oncology -
Elizabeth Seashore
MD
Pediatric Hematology-Oncology -
Elliot Stieglitz
MD
Pediatric Hematology-Oncology, Medical Oncology -
Alejandro Sweet-Cordero
MD
Hematology and Medical Oncology, Medical Oncology -
Russell Valle
MD
Pediatric Hematology-Oncology -
Natalie Wu
MD, MS
Pediatric Hematology-Oncology -
Elizabeth (Betsy) Young
MD
Pediatric Hematology-Oncology -
Kathryn Aaronson
NP
Pediatrics -
Judith Cavazos
PhD
Psychology -
Jenny Chen
RD
-
Lea Fox
NP, MSN
Pediatric Hematology-Oncology -
Carly Hoffman
NP, RN
Pediatrics -
Fabienne Hollinger
NP
Pediatric Hematology-Oncology -
Jennifer Murphy
NP, BSN
Pediatric Hematology-Oncology (Neuro-Oncology) -
Shannon Raber
MS, CPNP, RN
-
Erica Southworth
NP
Pediatrics -
Erin Esaki
PA
Pediatrics
-
Anuradha Banerjee
MD
Pediatric Hematology-Oncology -
Benjamin S. Braun
MD, PhD
Hematology and Medical Oncology, Medical Oncology -
Maria I. Castellanos
MD
Pediatric Hematology-Oncology -
Robert E. Goldsby
MD
Hematology and Medical Oncology, Medical Oncology -
Caroline Hastings
MD
Pediatric Hematology-Oncology (Neuro-Oncology), Pediatric Hematology-Oncology -
Benjamin J. Huang
MD
Hematology and Medical Oncology, Medical Oncology -
Marie Jaeger-Krause
MD
Pediatric Hematology-Oncology (Neuro-Oncology), Pediatric Hematology-Oncology -
Rohini Jain
MD
Pediatric Hematology-Oncology -
Benjamin Lerman
MD
Pediatric Hematology-Oncology -
Anya Levinson
MD
Pediatric Hematology-Oncology -
Amanda Marinoff
MD
Pediatric Hematology-Oncology -
Jennifer Michlitsch
MD
Pediatric Hematology-Oncology -
Sabine Mueller
MD, PhD
Pediatric Hematology-Oncology (Neuro-Oncology), Pediatric Neurology -
Brian S. Na
MD, PhD
Neuro-Oncology -
Philip Pauerstein
MD, PhD
Pediatrics, Pediatric Hospital Medicine -
Cheryl Peretz
MD
Pediatric Hematology-Oncology -
Bo Qiu
MD, PhD
Pediatrics -
Karen Rabin
MD, PhD
Pediatric Hematology-Oncology -
Ruyan Rahnama
MD, PhD
Pediatric Hematology-Oncology -
Alyssa Reddy
MD
Pediatric Neurology -
Elizabeth Robbins
MD
Hematology and Medical Oncology, Medical Oncology -
Amit J. Sabnis
MD, MS
Hematology and Medical Oncology, Medical Oncology -
Elizabeth Seashore
MD
Pediatric Hematology-Oncology -
Elliot Stieglitz
MD
Pediatric Hematology-Oncology, Medical Oncology -
Alejandro Sweet-Cordero
MD
Hematology and Medical Oncology, Medical Oncology -
Russell Valle
MD
Pediatric Hematology-Oncology -
Natalie Wu
MD, MS
Pediatric Hematology-Oncology -
Shuo Xu
MD
Hematology and Medical Oncology -
Elizabeth (Betsy) Young
MD
Pediatric Hematology-Oncology
Special programs
Awards & recognition
-
Top 10 in the nation and best in Northern California for cancer care
-
Ranked among the nation's best in 11 specialties
-
Designated an early phase clinical trials core site by the Children's Oncology Group
UCSF's Pediatric Cancer Program
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
- Completed medical forms that we will mail to you ahead of time
Related clinics (6)
2
Bone Marrow Transplant, Cellular and Gene Therapy Program
7
Hematology Clinic
Support services
Clinical trials
International Rare Brain Tumor Registry
The primary outcome measure will be time from diagnosis to an event, defined as the occurrence of progression or recurrence of the disease, occurrence of a second malignant neoplasm, or death from any cause. Each cohort will be an...
Recruiting
More about this studyA Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patien...
The Kaplan-Meier method will be used to estimate 3-year EFS, defined as the time from study entry until induction failure, relapse, or death.
Recruiting
More about this studyTesting the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Bl...
For the safety phase, DLTs of the induction + venetoclax cycle of KMT2A-rearranged (R) patients will be assessed.
Recruiting
More about this studyCabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Toxicity will be graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 (v5.0).
Recruiting
More about this studyMobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
The knowledge of the participant will be measured using a 12-item questionnaire that assesses the awareness of their treatment and health issues in four categories: (1) diagnosis, (2) treatment, (3) risks, and (4) recommended foll...
Recruiting
More about this studyOur research initiatives
Translation, please
We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.
Request an interpreter
